Carregant...
Role of FXR in Liver Inflammation during Nonalcoholic Steatohepatitis
PURPOSE OF REVIEW: About 15–25% of patients with simple steatosis of non-alcoholic fatty liver disease progresses to non-alcoholic steatohepatitis (NASH), and the underlying mechanism for this progression has not been elucidated. NASH ultimately could progress to cirrhosis, an irreversible condition...
Guardat en:
| Publicat a: | Curr Pharmacol Rep |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5624538/ https://ncbi.nlm.nih.gov/pubmed/28983452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40495-017-0085-2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|